DYN
DYN
NASDAQ · Biotechnology

Dyne Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$17.11
-0.95 (-5.26%)
As of Sep 20, 10:03 PM ET ·
Analyst Consensus
Strong Buy
21
Analysts
High
Coverage
Buy 19 90%
Hold 2 10%
Sell 0 0%
Price Target
Analyst Price Target +471.9% upside
Low Target $76.65
Average Target $97.86
High Target $132.93
Current Price $17.11
Current
$17.11
Target
$97.86
$76.65 $97.86 avg $132.93
Scenario Analysis
Bear Case
$76.65
348.0%
Low target
Base Case
$97.86
+471.9%
Avg target
Bull Case
$132.93
+676.9%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$27.31
-37.3% from high
52-Week Low
$11.92
+43.5% from low
50-Day SMA
$18.16
-5.8% vs SMA
200-Day SMA
$14.91
+14.8% vs SMA
RSI (14)
28.7
Oversold
Target vs 52W High
$97.86
+258.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -2.6%
AMGN
Amgen Inc
 Hold 43 47% $190.87 -51.5%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +140.9%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 36 81% $438.34 -14.2%
REGN
Regeneron Pharmaceuticals
 Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
 Hold 30 37% $149.45 -13.6%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -61.4%
RVMD
Revolution Medicines Inc
 Strong Buy 28 93% $114.11 -40.8%